Chronic kidney disease (CKD) is the leading cause of kidney failure, end-stage kidney disease (ESKD), and cardiovascular (CV) events in patients with type 2 diabetes (T2D). The FIDELIO-DKD trial demon

Figshare2025-01-09 更新20

Table 3_Cost-effectiveness analysis of irinotecan hydrochloride liposome in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma.xlsx

药物经济学评估

胰腺癌治疗

ObjectiveThis study aims to evaluate the cost-effectiveness of irinotecan hydrochloride liposome in combination with 5-fluorouracil and leucovorin (5-FU/LV) as a second-line treatment in locally advan

NIAID Data Ecosystem10

Supplementary materials: Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.docx

药物经济学评估

皮肤T细胞淋巴瘤

Table A1. Clinical Inputs. Table A2. Cost Inputs. Table A3: Resource utilization. Table A4. Utility inputs. Figure A1. Probabilistic sensitivity analysis scatterplot.

DataCite Commons2021-12-09 更新40

Incremental Costs, Revenues and Outcomes with PCSK9 (Per Patient. Health System’s and Payer’s Perspective) 1/ .

药物经济学评估

心血管治疗成本分析

Incremental Costs, Revenues and Outcomes with PCSK9 (Per Patient. Health System’s and Payer’s Perspective) 1/.

NIAID Data Ecosystem20